Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

Lymphoma Cells Are Retained in Gliotic Nervous-System Tissue

DOI: 10.1158/2159-8290.CD-RW2019-146 Published November 2019
  • Article
  • Info & Metrics
  • PDF
Loading
  • Major Finding: Lymphoma cells were more likely to take hold in gliotic central nervous systems (CNS) in mice.

  • Mechanism: Astrocytic CCL19 appeared responsible for retention of lymphoma cells in the CNS in mice and humans.

  • Impact: Age-related gliosis may partially explain the increased incidence of CNS lymphomas with age.


Embedded Image

Lymphomas may arise in or disseminate to the central nervous system (CNS), but how this occurs is unclear. O'Connor and colleagues developed a mouse model with high expression of lymphotoxins α and β (LTα and LTβ) in the CNS, resulting in chronic gliosis without severe damage to neurons or breakdown of the blood–brain barrier. This chronic gliosis conferred increased susceptibility to developing CNS lymphoma following intravenous injection of either of two types of neoplastic B cells. Although the expression of several leukocyte-specific cell-adhesion molecules (CAM) was upregulated in mice with CNS overexpression of LTα and LTβ, CAM upregulation alone was not sufficient to cause CNS lymphoma. Following injection of lymphoma cells, chronic gliosis was associated with an increase in parenchymal lymphoma cells. Though lymphoma cells also entered wild-type brain parenchyma, wild-type mice rarely developed CNS lymphoma. A possible explanation for this phenomenon is that lymphoma cells were more prone to being retained in the brain parenchyma in mice with chronic gliosis. Astrocyte-generated CCL19 and lymphoma cell–expressed CCR7 were required for the retention of lymphoma cells in the gliotic mouse brains, and evidence of this mechanism was also observed in biopsies from patients with primary and secondary CNS lymphoma. In concordance with the facts that gliosis increases with age and that the average age of onset for primary CNS lymphoma is 65 years, larger B220+ lesions developed in the brains of aged mice with gliosis than in younger mice following lymphoma-cell injection. Collectively, this work provides mechanistic insight into the relationship between aging-related gliosis and the development of CNS lymphoma and provides clues about possible risk factors for the disease.

O'Connor T, Zhou X, Kosla J, Adili A, Garcia Beccaria M, Kotsiliti E, et al. Age-related gliosis promotes central nervous system lymphoma through CCL19-mediated tumor cell retention. Cancer Cell 2019:36;250–67.E9.

Notes

Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/CDNews.

  • ©2019 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Discovery: 9 (11)
November 2019
Volume 9, Issue 11
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Lymphoma Cells Are Retained in Gliotic Nervous-System Tissue
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lymphoma Cells Are Retained in Gliotic Nervous-System Tissue
Cancer Discov November 1 2019 (9) (11) 1479; DOI: 10.1158/2159-8290.CD-RW2019-146

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Lymphoma Cells Are Retained in Gliotic Nervous-System Tissue
Cancer Discov November 1 2019 (9) (11) 1479; DOI: 10.1158/2159-8290.CD-RW2019-146
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • In Vivo CRISPR Screen Identifies FLI1 as Regulator of Effector T Cells
  • Trial Supports Combination Treatment and New Target for Multiple Myeloma
  • Mitochondrial DNA Damage Triggers an IFN-Mediated Immune Response
Show more Research Watch

Lymphoma

  • Metabolic Adaptation to Lymphoma Suppresses NK-Cell Antitumor Function
  • TBL1XR1 Mutations Bias toward Memory B-cell Fate to Promote Lymphoma
  • Mutant EZH2 Drives Follicular Lymphoma by Altering B-cell Dependencies
Show more Lymphoma
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement